Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Pirson

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 2, 2011
Association of PKD2 (polycystin 2) mutations with left-right laterality defectsStanislas Bataille, Nathalie Demoulin, Olivier Devuyst, et al.
Kidney International|June 22, 2012
Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulationThien Anh Ho, Nathalie Godefroid, Damien Gruzon, et al.
Medicine|July 30, 2016
Complement activation and effect of eculizumab in scleroderma renal crisisArnaud Devresse, Selda Aydin, Moglie Le Quintrec, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2012
Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best PracticeWim Terryn, Pierre Cochat, Roseline Froissart, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 16, 2015
Lanreotide Reduces Liver Volume, But Might Not Improve Muscle Wasting or Weight Loss, in Patients With Symptomatic Polycystic Liver DiseaseFrederik Temmerman, Thien Ahn Ho, Ragna Vanslembrouck, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 6, 2002
Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantationEric Goffin, Jean-Pierre Devogelaer, Abdelhamid Lalaoui, et al.
Journal of the American Society of Nephrology : JASN|October 25, 2001
Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2: two facets of the same disease?Karin Dahan, Arno Fuchshuber, Stavroula Adamis, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 27, 2011
Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutationsGuillaume Bollée, Karin Dahan, Martin Flamant, et al.
Journal of Hepatology|July 5, 2014
Development and validation of a polycystic liver disease complaint-specific assessment (POLCA)Frederik Temmerman, Fabienne Dobbels, Thien Anh Ho, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 8, 2011
Recurrence and graft loss after kidney transplantation for henoch-schonlein purpura nephritis: a multicenter analysisNada Kanaan, Georges Mourad, Eric Thervet, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 2, 2011
Association of PKD2 (polycystin 2) mutations with left-right laterality defectsStanislas Bataille, Nathalie Demoulin, Olivier Devuyst, et al.
Kidney International|June 22, 2012
Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulationThien Anh Ho, Nathalie Godefroid, Damien Gruzon, et al.
Medicine|July 30, 2016
Complement activation and effect of eculizumab in scleroderma renal crisisArnaud Devresse, Selda Aydin, Moglie Le Quintrec, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2012
Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best PracticeWim Terryn, Pierre Cochat, Roseline Froissart, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 16, 2015
Lanreotide Reduces Liver Volume, But Might Not Improve Muscle Wasting or Weight Loss, in Patients With Symptomatic Polycystic Liver DiseaseFrederik Temmerman, Thien Ahn Ho, Ragna Vanslembrouck, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 6, 2002
Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantationEric Goffin, Jean-Pierre Devogelaer, Abdelhamid Lalaoui, et al.
Journal of the American Society of Nephrology : JASN|October 25, 2001
Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2: two facets of the same disease?Karin Dahan, Arno Fuchshuber, Stavroula Adamis, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 27, 2011
Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutationsGuillaume Bollée, Karin Dahan, Martin Flamant, et al.
Journal of Hepatology|July 5, 2014
Development and validation of a polycystic liver disease complaint-specific assessment (POLCA)Frederik Temmerman, Fabienne Dobbels, Thien Anh Ho, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 8, 2011
Recurrence and graft loss after kidney transplantation for henoch-schonlein purpura nephritis: a multicenter analysisNada Kanaan, Georges Mourad, Eric Thervet, et al.
Pageof 7